Scinai Immunotherapeutics (SCNI) Total Debt (2018 - 2026)
Scinai Immunotherapeutics (SCNI) posted Total Debt of $641000.0 for Q1 2026, up 2.89% sequentially from $623000.0 in Q4 2025.
Scinai Immunotherapeutics (SCNI) Total Debt (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Total Debt for 9 years, with the latest figure at $641000.0 in Q1 2026.
- Quarterly Total Debt changed N/A year-over-year to $641000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $641000.0 (changed N/A YoY) and the FY2025 annual result came in at $623000.0, down 8.92% from the prior year.
- Total Debt improved to $641000.0 in Q1 2026 per SCNI's latest filing, from $623000.0 in the prior quarter.
- Over five years, Total Debt peaked at $23.7 million in Q2 2023 and troughed at $623000.0 in Q4 2025.
- A 5-year average of $13.6 million and a median of $19.0 million in 2023 frame the typical range for Total Debt.
- The sharpest annual moves came in 2022 and 2023: Total Debt tumbled 99.98% in 2022, then soared 44.21% in 2023.
- Over 5 years, Total Debt stood at $20.5 million in 2022, then slipped by 3.42% to $19.8 million in 2023, then sank by 96.54% to $684000.0 in 2024, then slipped by 8.92% to $623000.0 in 2025, then gained by 2.89% to $641000.0 in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $641000.0, $623000.0, and $790000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Scinai Immunotherapeutics | 1.08 Mn | -3.11 Bn | -1.12 Mn | 641,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 641,000.00 |
| Dec 31, 2025 | 623,000.00 |
| Jun 30, 2025 | 790,000.00 |
| Dec 31, 2024 | 684,000.00 |
| Sep 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 20.18 Mn |
| Mar 31, 2024 | 19.90 Mn |
| Dec 31, 2023 | 19.76 Mn |
| Sep 30, 2023 | 18.98 Mn |
| Jun 30, 2023 | 23.69 Mn |
| Mar 31, 2023 | 21.85 Mn |
| Dec 31, 2022 | 20.46 Mn |
| Sep 30, 2022 | 16.94 Mn |
| Jun 30, 2022 | 16.43 Mn |
| Mar 31, 2022 | 22.28 Mn |
| Dec 31, 2021 | 27.54 Mn |
| Sep 30, 2021 | 21.80 Mn |
| Jun 30, 2021 | 70.30 Bn |
| Mar 31, 2021 | 68.32 Bn |
| Dec 31, 2020 | 66.51 Bn |